english.cbg-meb.nl
MEB and Swissmedic sign Memorandum of Understanding
The Medicines Evaluation Board (MEB) intends to intensify collaboration with its partner authority in Switzerland in the field of therapeutic product development and production. On 11 September 2018, MEB Chairman Ton de Boer and Executive Director Hugo Hurts signed a Memorandum of Understanding (MoU) with Swissmedic Director Raimund Bruhin.